Page 5,374«..1020..5,3735,3745,3755,376..5,3805,390..»

Many stroke patients don't call 911

Posted: Published on April 30th, 2013

By Steven Reinberg HealthDay Reporter TUESDAY, April 30 (HealthDay News) -- More than one-third of people having a stroke don't call 911, even though that's the fastest route to potentially lifesaving treatment, a new study reports. "Prompt diagnosis and early management is essential to decrease morbidity and mortality after stroke," said lead researcher Dr. James Ekundayo, an assistant professor of family and community medicine at Meharry Medical College in Nashville, Tenn. "If about one-third does not arrive by ambulance, the implication is that they will have delayed evaluation and treatment with lifesaving drugs," Ekundayo said. For patients with ischemic stroke -- a blood clot blocking a blood vessel in the brain -- prior research has shown that administration of clot-busting drugs within two hours of symptom onset greatly reduces the odds of disability three months later. Ischemic stroke is more common than hemorrhagic stroke, which occurs when a blood vessel bleeds into the brain. The study -- published April 29 in the journal Circulation: Cardiovascular Quality and Outcomes -- looked at how more than 200,000 stroke patients arrived at hospital emergency rooms from 2003 to 2010. About 64 percent arrived by ambulance and the rest used other forms of transportation, … Continue reading →

Comments Off on Many stroke patients don't call 911

Too Many Stroke Victims Fail to Use EMS for Fastest Trip to Treatment

Posted: Published on April 30th, 2013

E-mail this page to a friend! Health & Medicine for Senior Citizens Too Many Stroke Victims Fail to Use EMS for Fastest Trip to Treatment Ethnic minorities, rural residents least likely to call 911 at onset of a stroke as recommended by American Heart Association April 30, 2013 Time is critical to stroke victims but more than a third dont get to the hospital by ambulance, even though thats the fastest way to get help, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. Researchers studied records on more than 204,000 stroke patients arriving at emergency rooms at 1,563 hospitals participating in the American Heart Association/American Stroke Get With The Guidelines-Stroke quality improvement program in 2003-10. Emergency medical services (EMS) transported 63.7 percent of the patients, with the rest arriving in various other ways, researchers said. During a stoke emergency, quick treatment is critical. EMS transported 79 percent of those who got to the hospital within two hours of the start of their symptoms. That resulted in earlier arrival, quicker evaluation and faster treatment, said the researchers who found: Almost 61 percent of people transported by EMS got to the hospital within three hours … Continue reading →

Comments Off on Too Many Stroke Victims Fail to Use EMS for Fastest Trip to Treatment

Stroke victims delay crucial treatment

Posted: Published on April 30th, 2013

Despite public outreach campaigns, a third of all stroke patients don't call an ambulance to get them to the hospital, leaving them vulnerable to delayed treatment and worse outcomes, according to a new study published in the journal Circulation. The authors analyzed data on more than 204,000 patients, seen at 1,563 U.S. hospitals between 2003 and 2010. Patients who arrived by ambulance were about twice as likely to arrive at a hospital quickly, and were about 50 percent more likely to receive intravenous TPA -- a clot-busting drug -- within the recommended three-hour window, when it's most effective. "Time is the essence," said Dr. O. James Ekundayo, the study's lead author and an assistant professor at Meharry Medical College in Nashville. "The earlier to the hospital, the better -- the earlier you're evaluated and given treatment." "Time is brain," adds Dr. Carolyn Brockington, director of the Stroke Center at St. Luke's-Roosevelt Hospital in New York. She says about 85 percent of strokes are caused by a blockage in a blood vessel in the brain, which TPA can help unclog. "People need to understand that every moment the brain is not getting enough blood flow, is producing an irreversible injury," Brockington … Continue reading →

Comments Off on Stroke victims delay crucial treatment

North American Seminars Introduces A Significant Advancement in Spinal Cord Rehab Continuing Medical Education for …

Posted: Published on April 30th, 2013

Franklin, TN (PRWEB) April 29, 2013 North American Seminars sought out the top rehab professional in the United States while researching the topic of spinal cord rehab. With 6 million people or approximately 1 in 50 people living with some sort of paralysis we knew that this issue effects almost every American in some way. Selina Morgan PT, ATP delivers not only current evidence based evaluation and treatment techniques for Spinal Cord Injury, but an overwhelming compassion for this population. Filming two young adults with paralysis conveys the difficulty, challenges and rewards of working with this population. This film is a unique physical therapy continuing education program featuring a paraplegic and a quadriplegic performing specific rehab activities. As a PT continuing education online course, North American Seminars applied the content in the film to evidence based clinical information. This online continuing education course for PT and OT discusses the following areas of Spinal Cord Rehab: In addition, extensive instruction in the continuing education online course for PT and OT discusses Manual Muscle Testing including: Approved online continuing education for PT and PTA This course meets the continuing education requirements for physical therapists in the States of California, Illinois, New York, … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on North American Seminars Introduces A Significant Advancement in Spinal Cord Rehab Continuing Medical Education for …

InVivo Therapeutics’ CEO Scheduled to Appear on FOX Business Network’s “Varney & Company”

Posted: Published on April 30th, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that CEO Frank Reynolds is scheduled to appear live in New York City on FOX Business Networks Varney & Company on Tuesday, April 30th at approximately 10:25am ET. Varney & Company is a program hosted by veteran business journalist Stuart Varney that airs weekdays from 9:20am to 11:00am ET, giving over two million viewers the 411 on Wall Street. InVivo Therapeutics has pioneered a treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after traumatic SCI. On the show, Reynolds will discuss this first product, the upcoming pilot study, and the platform the Company has built for developing new treatment options for a range of neurotrauma conditions tapping a more than $23 billion market opportunity. Recently, the U.S. Food and Drug Administration (FDA) granted two approvals to the Company, the first for Humanitarian Use Device (HUD) designation, which the Company believes will expedite the products path to market, and the second to approve the … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics’ CEO Scheduled to Appear on FOX Business Network’s “Varney & Company”

Spinal Injury Treatment in Thailand by Vejthani Hospital

Posted: Published on April 30th, 2013

BANGKOK--(BUSINESS WIRE)-- Vejthani Hospital Bangkok offers Spinal Injury Treatment to solve your spine problem at Vejthani spine center in Thailand. We will analyze for the appropriate care tailored to the needs of each patient suffering from spinal injury. A spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease. Depending on where the spinal cord and nerve roots are damaged, the symptoms can vary widely, from pain to paralysis to incontinence. Spinal cord injuries are described at various levels of "incomplete", which can vary from having no effect on the patient to a "complete" injury which means a total loss of function. Spinal injury can occur without trauma. Many people suffer transient loss of function ("stingers") in sports accidents or pain in whiplash of the neck without neurological loss and relatively few of these suffer spinal cord injury sufficient to warrant hospitalization. Treatment of spinal cord injuries starts with restraining the spine and controlling inflammation to prevent further damage. The actual treatment can vary widely depending on the location and extent of the injury. In many cases, spinal cord injuries require substantial physical therapy and rehabilitation, especially if the patient's … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on Spinal Injury Treatment in Thailand by Vejthani Hospital

April is Parkinson's awareness month – Montréal's tourism industry mobilizes to welcome the 3rd World Parkinson Congress

Posted: Published on April 30th, 2013

October 1-4, 2013 MONTREAL, April 29, 2013 /CNW Telbec/ - World Parkinson Coalition and Parkinson Society Canada will co-host the next World Parkinson Congress (WPC) in October 2013 in Montral. More than 3,500 delegates from over 60 countries are expected to attend this major event, which is the only global conference that brings together the entire Parkinson's community, including people with Parkinson's, those who care for them, medical professionals, policy makers and researchers working toward a cure and better treatments. During April, which is Parkinson's awareness month, Tourisme Montral wants to underscore the fact that all members of Montral's tourism industry are getting ready to welcome these worldwide delegates, many of whom view coming to the Congress as a life-changing experience and a dream fulfilled. "Welcoming the third World Parkinson Congress to Montral is a unique opportunity for the country and for the Qubec Parkinson's community. Being part of this global family and having access to leading researchers and the latest treatment innovations and knowledge will leave a lasting impression for people with Parkinson's. Individuals will share their experiences with those who live similar realities, all contributing to making this an exceptional event not to be missed. We are pleased … Continue reading →

Posted in Parkinson's Treatment | Comments Off on April is Parkinson's awareness month – Montréal's tourism industry mobilizes to welcome the 3rd World Parkinson Congress

Impax, GSK end Parkinson's disease partnership

Posted: Published on April 30th, 2013

(Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax shares fell 2 percent to $17.32 in premarket trade after closing at $17.62 on Friday on the Nasdaq. Under a deal, GlaxoSmithKline had the right to develop and market the drug, IPX066, outside the United States and Taiwan. Rights to the drug, which is known as Rytary in the United States, will transfer back to Impax at the end of July 2013. Impax did not disclose the financial impact of the deal termination, if any. It said it plans to find a partner or partners for markets outside the United States. Rytary is an extended-release capsule being developed for the symptomatic treatment of adult patients with idiopathic Parkinson's disease. (Reporting by Esha Dey in Bangalore; Editing by Sreejiraj Eluvangal) See the article here: Impax, GSK end Parkinson's disease partnership … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Impax, GSK end Parkinson's disease partnership

Family seeks better brain injury care

Posted: Published on April 30th, 2013

Almost two years ago, Garrison Leif Sandberg, a junior at Napa High, was near death from injuries he sustained as a passenger in a DUI-related crash near Napa. Today, at 19, Sandberg walks without a cane. His shaking has subsided and he can speak. Key to his ongoing recovery, his parents, Eric and Suzanne Sandberg said, was the medical and rehabilitation therapy Leif Sandberg received for nine months at Centre for Neuro Skills in Bakersfield. However, that long-term inpatient therapy, which ended in April 2012 and cost about $300,000, was not covered under the familys Blue Shield health policy plan, the Sandbergs said. The Sandbergs will travel to Sacramento Wednesday to show support for Senate Bill 320 that would prohibit insurance companies from denying long-term therapy for brain injury patients. The Sandbergs will take a stack of signatures in support of the bill, which the California Senate Health Committee is scheduled to discuss. State Sen. Jim Beall, D-San Jose, introduced the bill in February with the backing of the Brain Injury Association of California, which estimates about 350,000 Californians live with a traumatic brain injury. If approved, S.B. 320 would take effect Jan. 1, 2014. The goal is to come … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Family seeks better brain injury care

Oxygen Biotherapeutics Announces It is Set to Begin Enrolling Patients in the Second Cohort of Its STOP-TBI Clinical …

Posted: Published on April 30th, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)-- Oxygen Biotherapeutics, Inc. (OBI) (OXBT), today announced the initiation of the second cohort of its Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain injury (STOP-TBI). The second cohort begins officially with the activation of the first of five planned sites in Israel. This trial site will receive its first shipment of Oxycyte this week and can immediately begin enrollment. Resuming enrollment in the second cohort of our TBI trial is a critical milestone in the development of Oxycyte, said Michael Jebsen, President and Chief Financial Officer of OBI. We have spent the last year focused on securing long-term supply of clinical trial material and retaining a contract research organization with the ability to effectively manage an international clinical trial. Bringing Oxycyte to market as a treatment for acute ischemic conditions, such as TBI, remains the top priority of OBI. The STOP-TBI trial is a randomized, double-blind, placebo-controlled dose-escalation study in which a single intravenous administration of Oxycyte is given to patients in conjunction with supplemental oxygen. The primary objective of the trial is to evaluate the safety and tolerability of Oxycyte in patients with severe non-penetrating … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Oxygen Biotherapeutics Announces It is Set to Begin Enrolling Patients in the Second Cohort of Its STOP-TBI Clinical …

Page 5,374«..1020..5,3735,3745,3755,376..5,3805,390..»